Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.380
+0.090 (2.74%)
At close: Mar 9, 2026, 4:00 PM EDT
3.420
+0.040 (1.18%)
After-hours: Mar 9, 2026, 4:41 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $76.60 million as of March 9, 2026. Its market cap has increased by 14.90% in one year.
Market Cap
76.60M
Enterprise Value
66.85M
1-Year Change
14.90%
Ranking
Category
Stock Price
$3.38
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $76.60M, an increase of 21.39%. That is a compound annual growth rate of 3.04%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myriad Genetics | 481.57M |
| Fulgent Genetics | 456.90M |
| Prenetics Global | 299.55M |
| Burning Rock Biotech | 239.56M |
| Biodesix | 185.14M |
| Insight Molecular Diagnostics | 175.31M |
| MDxHealth | 167.96M |
| FONAR | 121.21M |